⌘K

Home/Filings/4/0001415889-25-004406

4//SEC Filing

Attar Eyal C. 4

Accession 0001415889-25-004406

CIK 0001817229other

View on SEC.gov Company Profile

Filed

Feb 17, 7:00 PM ET

Accepted

Feb 18, 4:20 PM ET

Size

4.9 KB

Accession

0001415889-25-004406

Insider Transaction Report

Form 4

Period: 2025-02-13

Vor Biopharma Inc.VOR

CHIEF MEDICAL OFFICER

Transactions

Sale
Common Stock
2025-02-13$1.42/sh−2,227$3,162→ 126,625 total

Footnotes (1)

[F1]The transaction was pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 4, 2024.

Documents

1 file

4
form4-02182025_090225.xmlPrimary

Issuer

Vor Biopharma Inc.

CIK 0001817229

Entity typeother

Related Parties

1

filerCIK 0001789076

Filing Metadata

Form type: 4
Filed: Feb 17, 7:00 PM ET
Accepted: Feb 18, 4:20 PM ET
Size: 4.9 KB

View on SEC.gov